Rifapentine and isoniazid for latent tuberculosis [1]

James R. Johnson

doi:10.1056/NEJMc1200489

Rifapentine and isoniazid for latent tuberculosis [1]

James R. Johnson

Medicine - Veteran's Administration Medical Center

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	1447-1448
Number of pages	2
Journal	New England Journal of Medicine
Volume	366
Issue number	15
DOIs	https://doi.org/10.1056/NEJMc1200489
State	Published - Apr 12 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1056/NEJMc1200489

OpenUrl availability

Full text

Cite this

@article{e293cc8de7094b91aa1540f653ff17cb,

title = "Rifapentine and isoniazid for latent tuberculosis [1]",

author = "Johnson, {James R.}",

year = "2012",

month = apr,

day = "12",

doi = "10.1056/NEJMc1200489",

language = "English (US)",

volume = "366",

pages = "1447--1448",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "15",

}

TY - JOUR

T1 - Rifapentine and isoniazid for latent tuberculosis [1]

AU - Johnson, James R.

PY - 2012/4/12

Y1 - 2012/4/12

UR - http://www.scopus.com/inward/record.url?scp=84859541136&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859541136&partnerID=8YFLogxK

U2 - 10.1056/NEJMc1200489

DO - 10.1056/NEJMc1200489

M3 - Letter

C2 - 22494128

AN - SCOPUS:84859541136

SN - 0028-4793

VL - 366

SP - 1447

EP - 1448

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 15

ER -

Rifapentine and isoniazid for latent tuberculosis [1]

UN SDGs

Access

OpenUrl availability

Other files and links

Cite this